The results showed that p-AKT levels were significantly decreased in gastric cancer cells overexpressing TOB1 compared with control cells (Figs. 5A and 5B, *P = 0.0459), indicating that overexpression of the TOB1 gene can inhibit AKT phosphorylative activation. The gene discussed is TOB1; the disease is gastric cancer.